Table 4 Univariate and multiple analyses of factors associated with the clinical response at 6 months
Characteristics | OR | 95% CI | p | aOR | 95% CI | p |
|---|---|---|---|---|---|---|
HPV positive | 31.1 | 1.8–531.1 | 0.018 | 31.1 | 1.8–531.1 | 0.018 |
Female gender | 10.1 | 1.4–73.0 | 0.022 | |||
P16 positive | 8.3 | 2.0–34.2 | 0.003 | |||
Age < 65 years | 1.1 | 0.6–2.0 | 0.662 | |||
Degree of cell differentiation I and II | 1.3 | 0.6–2.5 | 0.586 | |||
Clinical stage I and II | 2.5 | 1.3–5.0 | 0.008 | |||
T 2/3 | 1.2 | 0.5–3.1 | 0.675 | |||
TP53 mutated | 0.1 | 0.03–0.5 | 0.003 |